BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nie D, Hu Y, Chen Z, Li M, Hou Z, Luo X, Mao X, Xue X. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci 2020;27:26. [PMID: 31954394 DOI: 10.1186/s12929-020-0617-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaushik V, Tiwari M, Joshi R, Tiwari V. Therapeutic strategies against potential antibiofilm targets of multidrug-resistant Acinetobacter baumannii. J Cell Physiol 2022. [PMID: 35083758 DOI: 10.1002/jcp.30683] [Reference Citation Analysis]
2 Puentes PR, Henao MC, Torres CE, Gómez SC, Gómez LA, Burgos JC, Arbeláez P, Osma JF, Muñoz-Camargo C, Reyes LH, Cruz JC. Design, Screening, and Testing of Non-Rational Peptide Libraries with Antimicrobial Activity: In Silico and Experimental Approaches. Antibiotics (Basel) 2020;9:E854. [PMID: 33265897 DOI: 10.3390/antibiotics9120854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 El Karkouri J, Bouhrim M, Al Kamaly OM, Mechchate H, Kchibale A, Adadi I, Amine S, Alaoui Ismaili S, Zair T. Chemical Composition, Antibacterial and Antifungal Activity of the Essential Oil from Cistus ladanifer L. Plants (Basel) 2021;10:2068. [PMID: 34685879 DOI: 10.3390/plants10102068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Han L, Gao Y, Liu Y, Yao S, Zhong S, Zhang S, Wang J, Mi P, Wen Y, Ouyang Z, Zhang J, Al-Shamiri MM, Li P, Han S. An Outer Membrane Protein YiaD Contributes to Adaptive Resistance of Meropenem in Acinetobacter baumannii. Microbiol Spectr 2022;:e0017322. [PMID: 35377216 DOI: 10.1128/spectrum.00173-22] [Reference Citation Analysis]
5 Li Z, Ding Z, Liu Y, Jin X, Xie J, Li T, Zeng Z, Wang Z, Liu J. Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii. Infect Drug Resist 2021;14:2613-24. [PMID: 34262306 DOI: 10.2147/IDR.S310081] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hamidian M, Maharjan RP, Farrugia DN, Delgado NN, Dinh H, Short FL, Kostoulias X, Peleg AY, Paulsen IT, Cain AK. Genomic and phenotypic analyses of diverse non-clinical Acinetobacter baumannii strains reveals strain-specific virulence and resistance capacity. Microb Genom 2022;8. [PMID: 35166651 DOI: 10.1099/mgen.0.000765] [Reference Citation Analysis]
7 Ma C, McClean S. Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It. Vaccines (Basel) 2021;9:570. [PMID: 34205838 DOI: 10.3390/vaccines9060570] [Reference Citation Analysis]
8 Bharathi SV, Venkataramaiah M, Rajamohan G. Genotypic and Phenotypic Characterization of Novel Sequence Types of Carbapenem-Resistant Acinetobacter baumannii, With Heterogeneous Resistance Determinants and Targeted Variations in Efflux Operons. Front Microbiol 2021;12:738371. [PMID: 35002996 DOI: 10.3389/fmicb.2021.738371] [Reference Citation Analysis]
9 Yeganeh O, Shabani M, Pakzad P, Mosaffa N, Hashemi A. Production and characterization of novel monoclonal antibodies against outer membrane protein A (OmpA) of Acinetobacter baumannii. J Immunol Methods 2021;499:113169. [PMID: 34666009 DOI: 10.1016/j.jim.2021.113169] [Reference Citation Analysis]
10 Khalid K, Irum S, Ullah SR, Andleeb S. In-Silico Vaccine Design Based on a Novel Vaccine Candidate Against Infections Caused by Acinetobacter baumannii. Int J Pept Res Ther 2022;28:16. [PMID: 34873398 DOI: 10.1007/s10989-021-10316-7] [Reference Citation Analysis]
11 Kwofie SK, Adobor C, Quansah E, Bentil J, Ampadu M, Miller WA 3rd, Wilson MD. Molecular docking and dynamics simulations studies of OmpATb identifies four potential novel natural product-derived anti-Mycobacterium tuberculosis compounds. Comput Biol Med 2020;122:103811. [PMID: 32479349 DOI: 10.1016/j.compbiomed.2020.103811] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li S, Chen DQ, Ji L, Sun S, Jin Z, Jin ZL, Sun HW, Zeng H, Zhang WJ, Lu DS, Luo P, Zhao AN, Luo J, Zou QM, Li HB. Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy. Front Immunol 2020;11:1069. [PMID: 32655550 DOI: 10.3389/fimmu.2020.01069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Roy R, You RI, Chang CH, Yang CY, Lin NT. Carboxy-Terminal Processing Protease Controls Production of Outer Membrane Vesicles and Biofilm in Acinetobacter baumannii. Microorganisms 2021;9:1336. [PMID: 34203028 DOI: 10.3390/microorganisms9061336] [Reference Citation Analysis]
14 Liu H, Cao CY, Qiu FL, Huang HN, Xie H, Dong R, Shi YZ, Hu XN. Iron-Rich Conditions Induce OmpA and Virulence Changes of Acinetobacter baumannii. Front Microbiol 2021;12:725194. [PMID: 34675899 DOI: 10.3389/fmicb.2021.725194] [Reference Citation Analysis]
15 Kumar S, Anwer R, Azzi A. Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii. Microorganisms 2021;9:2104. [PMID: 34683425 DOI: 10.3390/microorganisms9102104] [Reference Citation Analysis]
16 Song X, Zhao G, Ding M. Antigen Epitope Developed Based on Acinetobacter baumannii MacB Protein Can Provide Partial Immune Protection in Mice. Biomed Res Int 2020;2020:1975875. [PMID: 33134372 DOI: 10.1155/2020/1975875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lin L, Capozzoli R, Ferrand A, Plum M, Vettiger A, Basler M. Subcellular localization of Type VI secretion system assembly in response to cell–cell contact. The EMBO Journal. [DOI: 10.15252/embj.2021108595] [Reference Citation Analysis]
18 Grund ME, Soo JC, Cote CK, Berisio R, Lukomski S. Thinking Outside the Bug: Targeting Outer Membrane Proteins for Burkholderia Vaccines. Cells 2021;10:495. [PMID: 33668922 DOI: 10.3390/cells10030495] [Reference Citation Analysis]
19 Liu P, Chang H, Xu Q, Wang D, Tang Y, Hu X, Lin M, Liu Z. Peptide Aptamer PA3 Attenuates the Viability of Aeromonas veronii by Hindering of Small Protein B-Outer Membrane Protein A Signal Pathway. Front Microbiol 2022;13:900234. [DOI: 10.3389/fmicb.2022.900234] [Reference Citation Analysis]
20 Li H, Du X, Chen C, Qi J, Wang Y. Integrating transcriptomics and metabolomics analysis on kojic acid combating Acinetobacter baumannii biofilm and its potential roles. Microbiol Res 2022;254:126911. [PMID: 34763140 DOI: 10.1016/j.micres.2021.126911] [Reference Citation Analysis]
21 Jothipandiyan S, Suresh D, Sankaran SV, Thamotharan S, Shanmugasundaram K, Vincent P, Sekaran S, Gowrishankar S, Pandian SK, Paramasivam N. Heteroleptic pincer palladium(II) complex coated orthopedic implants impede the AbaI/AbaR quorum sensing system and biofilm development by Acinetobacter baumannii. Biofouling 2021;:1-16. [PMID: 34961388 DOI: 10.1080/08927014.2021.2015336] [Reference Citation Analysis]
22 Monem S, Furmanek-Blaszk B, Łupkowska A, Kuczyńska-Wiśnik D, Stojowska-Swędrzyńska K, Laskowska E. Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment. Int J Mol Sci 2020;21:E5498. [PMID: 32752093 DOI: 10.3390/ijms21155498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Oh KW, Kim K, Islam MM, Jung HW, Lim D, Lee JC, Shin M. Transcriptional Regulation of the Outer Membrane Protein A in Acinetobacter baumannii. Microorganisms 2020;8:E706. [PMID: 32403355 DOI: 10.3390/microorganisms8050706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Cameranesi MM, Kurth D, Repizo GD. Acinetobacter defence mechanisms against biological aggressors and their use as alternative therapeutic applications. Crit Rev Microbiol 2021;:1-21. [PMID: 34289313 DOI: 10.1080/1040841X.2021.1939266] [Reference Citation Analysis]
25 Usmani Y, Ahmed A, Faizi S, Versiani MA, Shamshad S, Khan S, Simjee SU. Antimicrobial and biofilm inhibiting potential of an amide derivative [N-(2', 4'-dinitrophenyl)-3β-hydroxyurs-12-en-28-carbonamide] of ursolic acid by modulating membrane potential and quorum sensing against colistin resistant Acinetobacter baumannii. Microb Pathog 2021;157:104997. [PMID: 34048890 DOI: 10.1016/j.micpath.2021.104997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Khalil MAF, Ahmed FA, Elkhateeb AF, Mahmoud EE, Ahmed MI, Ahmed RI, Hosni A, Alghamdi S, Kabrah A, Dablool AS, Hetta HF, Moawad SS, Hefzy EM. Virulence Characteristics of Biofilm-Forming Acinetobacter baumannii in Clinical Isolates Using a Galleria mellonella Model. Microorganisms 2021;9:2365. [PMID: 34835490 DOI: 10.3390/microorganisms9112365] [Reference Citation Analysis]
27 Upmanyu K, Haq QMR, Singh R. Factors mediating Acinetobacter baumannii biofilm formation: Opportunities for developing therapeutics. Current Research in Microbial Sciences 2022;3:100131. [DOI: 10.1016/j.crmicr.2022.100131] [Reference Citation Analysis]
28 Impey RE, Hawkins DA, Sutton JM, Soares da Costa TP. Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria. Antibiotics (Basel) 2020;9:E623. [PMID: 32961699 DOI: 10.3390/antibiotics9090623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
29 Gallagher P, Baker S. Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii. Journal of Infection 2020;81:857-61. [DOI: 10.1016/j.jinf.2020.10.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Vale de Macedo GHR, Costa GDE, Oliveira ER, Damasceno GV, Mendonça JSP, Silva LDS, Chagas VL, Bazán JMN, Aliança ASDS, Miranda RCM, Zagmignan A, Monteiro AS, Nascimento da Silva LC. Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance. Pathogens 2021;10:148. [PMID: 33540588 DOI: 10.3390/pathogens10020148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 El-Kazzaz W, Metwally L, Yahia R, Al-Harbi N, El-Taher A, Hetta HF. Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden Community-Acquired Infections. Antibiotics (Basel) 2020;9:E603. [PMID: 32942596 DOI: 10.3390/antibiotics9090603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Tamez AM, McLaughlin RW, Li J, Wan X, Zheng J. Searching for putative virulence factors in the genomes of Shewanella indica and Shewanella algae. Arch Microbiol 2021;203:683-92. [PMID: 33040180 DOI: 10.1007/s00203-020-02060-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Skerniškytė J, Karazijaitė E, Lučiūnaitė A, Sužiedėlienė E. OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response. Pathogens 2021;10:407. [PMID: 33807410 DOI: 10.3390/pathogens10040407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Gudzuhn M, Alio I, Moll R, de Vries J, Boehlich J, Assmann M, Janneschütz J, Schützenmeister N, Himmelbach A, Poehlein A, Daniel R, Streit WR. Molecular Insight into Gene Response of Diorcinol- and Rubrolide-Treated Biofilms of the Emerging Pathogen Stenotrophomonas maltophilia. Microbiol Spectr 2022;:e0258221. [PMID: 35471093 DOI: 10.1128/spectrum.02582-21] [Reference Citation Analysis]
35 Schroven K, Aertsen A, Lavigne R. Bacteriophages as drivers of bacterial virulence and their potential for biotechnological exploitation. FEMS Microbiol Rev 2021;45:fuaa041. [PMID: 32897318 DOI: 10.1093/femsre/fuaa041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
36 Ma C, Chen W. Where are we and how far is there to go in the development of an Acinetobacter vaccine? Expert Rev Vaccines 2021;20:281-95. [PMID: 33554671 DOI: 10.1080/14760584.2021.1887735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Na SH, Jeon H, Oh MH, Kim YJ, Lee JC. Screening of small molecules attenuating biofilm formation of Acinetobacter baumannii by inhibition of ompA promoter activity. J Microbiol 2021;59:871-8. [PMID: 34449059 DOI: 10.1007/s12275-021-1394-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Singh R, Capalash N, Sharma P. Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review. 3 Biotech 2022;12:85. [PMID: 35261870 DOI: 10.1007/s13205-022-03148-9] [Reference Citation Analysis]
39 Law SKK, Tan HS. The Role of Quorum Sensing, Biofilm Formation, and Iron Acquisition as Key Virulence Mechanisms in Acinetobacter baumannii and the Corresponding Anti-virulence Strategies. Microbiological Research 2022. [DOI: 10.1016/j.micres.2022.127032] [Reference Citation Analysis]
40 Na SH, Jeon H, Oh MH, Kim YJ, Chu M, Lee IY, Lee JC. Therapeutic Effects of Inhibitor of ompA Expression against Carbapenem-Resistant Acinetobacter baumannii Strains. Int J Mol Sci 2021;22:12257. [PMID: 34830146 DOI: 10.3390/ijms222212257] [Reference Citation Analysis]
41 Shahryari S, Mohammadnejad P, Noghabi KA. Screening of anti-Acinetobacter baumannii phytochemicals, based on the potential inhibitory effect on OmpA and OmpW functions. R Soc Open Sci 2021;8:201652. [PMID: 34457318 DOI: 10.1098/rsos.201652] [Reference Citation Analysis]
42 Liao CH, Chang CL, Huang HH, Lin YT, Li LH, Yang TC. Interplay between OmpA and RpoN Regulates Flagellar Synthesis in Stenotrophomonas maltophilia. Microorganisms 2021;9:1216. [PMID: 34199787 DOI: 10.3390/microorganisms9061216] [Reference Citation Analysis]
43 Sarshar M, Behzadi P, Scribano D, Palamara AT, Ambrosi C. Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen. Pathogens 2021;10:387. [PMID: 33804894 DOI: 10.3390/pathogens10040387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
44 Mat Rahim N, Lee H, Strych U, AbuBakar S. Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development. Hum Vaccin Immunother 2021;:1-11. [PMID: 34106809 DOI: 10.1080/21645515.2021.1927412] [Reference Citation Analysis]
45 Uppalapati SR, Sett A, Pathania R. The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen. Front Microbiol 2020;11:589234. [PMID: 33123117 DOI: 10.3389/fmicb.2020.589234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]